Kymera Therapeutics ( ($KYMR) ) just unveiled an update. On December 9, 2025, Kymera Therapeutics announced an underwritten public offering of 7,00......

In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Kymera Therapeutics, with a price target of $116.......

Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Kymera Therapeutics today and set a price target of $125.00. Tenthoff covers the H......

In a report released today, Etzer Darout from Barclays maintained a Buy rating on Kymera Therapeutics, with a price target of $119.00. According to......

We have all of the latest stock market stories traders need to know about on Monday. ...

Kymera Therapeutics stock surged on Monday after the company announced strong clinical trial results. ...

Kymera Therapeutics ( ($KYMR) ) has issued an announcement. On December 8, 2025, Kymera Therapeutics discussed the results of their Phase 1b trial ......

The latest announcement is out from Kymera Therapeutics ( ($KYMR) ). On December 8, 2025, Kymera Therapeutics announced positive results from their......

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Kymera Therapeutics (KYMR – Research Report) and S......